"Designing Growth Strategies is in our DNA"

Cell Surface Markers Market Size, Share & Industry Analysis, By Product (Antibody, PCR Array), By Source (Human, Mouse, Rat, Others) , By Application (Research, Clinical, Others), By End User (Research Institutes, Pharmaceutical & Biotechnology Industry, Others) and Regional Forecast, 2021-2028

Region : Global | Report ID: FBI103129 | Status : Ongoing

 

KEY MARKET INSIGHTS

Proteins and carbohydrates attached to the cell membrane are known as cell surface markers. The cell surface markers help identifying the specific type of cell which is useful in studying various diseases. As per world health organization (WHO), globally about 9.6 million deaths occur due to cancer. Cell surface markers are a crucial aspect in studying oncology and hence are in greater demand. Extensive R&D in research institutes, pharmaceutical companies, and CROs has led to the increasing demand for cell surface markers such as PCR array and antibodies. Demand for effective drugs against chronic diseases is also the factor leading to the growth of cell surface markers market. Moreover, the markers help in identifying the ligands or the drug response which may prove useful in development of drugs. Depending on the immune response initiated by the cell type for a particular disease, researchers choose cell surface markers based on T-cell, B-cell or NK cells. Thus, surge in funding for R&D is the key factor for the market growth of the global cell surface markers.


The major factor driving the global cell surface markers market is investments in R&D for continuous launch of effective medicines and develop therapies such as stem cell, immunotherapy etc. Other factors driving the market includes an introduction of innovative and effective cell surface markers by the pharmaceutical & biotechnology industries to carry an extensive research.


On the flip side, to carry out the desired research the individual firm needs to invest in expensive instruments and reagents. But, start-ups and small scale industries lack financial resources, hence tend to minimise the use of expensive instruments ultimately affecting the sales of cell surface markers.


Key Market Driver -

Higher investments in R&D for launch of effective drugs

Key Market Restraint -

Unwillingness for high investment in sophisticated models


Market Segmentation:


By product, the market is segmented into antibodies and PCR array. Based on source, the market is segmented into human, mouse, rat, and others. Based on application, the market is categorised into research, clinical, and others. Based on end users, the cell surface markers market is segmented into research institutes, pharmaceutical & biotechnology industries, and others.


From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.


Key Players Covered:


The major companies in the global cell surface markers market report includes Thermo Fisher Scientific, QIAGEN N.V., Bio-Rad Laboratories, F. Hoffman-La Roche, BD, Grifols SA, GenScript, Siemens Healthcare Private Limited,  Abcam plc., and others.


Key Insights



  • New Advancements In Cell Surface Markers Market

  • Pipeline Analysis

  • Prevalence of Major Chronic Diseases – By Key Countries./Regions

  • Key Industry Developments – Mergers, Acquisitions, and Partnerships


Regional Analysis:


The global cell surface markers market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America followed by Europe dominated the global cell surface markers market in 2019, owing to the rise in R&D of the pharmaceutical & biotechnology industries. However, increasing patient pool suffering from chronic disease and demand for effective medications in Asia Pacific is likely to accelerate the growth of the market in this regions. This along with growing mergers and acquisitions between industry players and funds allotment by the regional and national government agencies, to promote the sales of the cell surface markers in countries like China, India, and other countries, is projected to further augment the demand for cell surface markers in Asia Pacific. Latin America and Middle East & Africa are projected to register a comparatively lower CAGR by the end of the forecast period.


To gain extensive insights into the market, Request for Customization


Segmentation






























 ATTRIBUTE


  DETAILS

By Product




  • Antibody

  • PCR Array



By Source




  • Human

  • Mouse

  • Rat

  • Others



By Application




  • Research

  • Clinical

  • Others



By End User




  • Research Institutes

  • Pharmaceutical & Biotechnology Industry

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



Cell Surface Markers Industry Developments



  • In April 2016, Abnova Corporation received worldwide license to CSV (Cell-surface vimentin) monoclonal antibody for cancer-specific circulating tumor cells from MD Anderson Cancer Center.

  • In December 2019, Neuro-sys SAS company entered into a partnership agreement with Sciomis GmbH to collaboratively develop solution for neurodegenerative disorders. Sciomis has expertise in biomarker discovery. This platform of the company will help Neuro-sys SAS for developing the solution.


Cell Surface Markers Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

abbvie
Ansell
Lek
Pfizer
Ipsos

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X